Core--Retroviral and AAV Vector

核心--逆转录病毒和AAV载体

• 批准号: 6774624
• 负责人: Arthur Dusty Miller
• 金额: $ 16.71万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-01-01 至 2008-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6774624
• 关键词: Retroviridae; adeno associated virus group; biomedical facility; biotechnology; transfection /expression vector

The original goal of the Vector Core was to provide Center investigators with services relating to the development of gene transfer vectors required for clinical gene therapy protocols. This included providing vectors available with current technology and the development of new approaches based upon investigator needs. The Vector Core would be responsible for maintaining good laboratory practices consistent with RAC and FDA requirements for vectors to be used in humans, and would assist investigators in securing approval for gene therapy trials.

Vector Core的最初目标是为中心研究人员提供服务 涉及临床基因治疗方案所需的基因转移载体的开发。 这包括提供现有技术的载体和开发新的 根据研究者的需要。矢量核心将负责 保持良好的实验室规范符合RAC和FDA对用于人类的载体的要求，并将协助研究人员确保基因治疗试验的批准。